Karyopharm Therapeutics | KPTI - Kapitał Akcyjny





Kapitał Akcyjny Zmiana Data
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 2.94M 2026-03
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 943.5M 3.33M 2026-03
Enanta Pharmaceuticals USD 212K 1000 2023-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Incyte USD 199.95M 1.49M 2026-03
J&J USD 2.41B 1.35M 2026-03
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
MacroGenics USD 63.56M 241K 2026-03
Merck USD 2.47B 12.72M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novartis USD 1.91B 60K 2026-03
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 13M 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Takeda JPY 1.58B 241K 2026-03
Tectonic Therapeutic USD 18.83M 92.19K 2026-03
TG Therapeutics USD 155.31M 95K 2025-12
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
Xencor USD 74.06M 2.19M 2026-03